Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Compare the Efficacy and Safety of Denosumab Versus Placebo in Males With Low Bone Mineral Density

NCT00980174 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00980174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00980174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Compare the Efficacy and Safety of Denosumab Versus Placebo in Males With Low Bone Mineral Density
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
October 1, 2009
Completion date
May 23, 2012
Enrollment
242 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

low bone mass, low bone mineral density, males with osteoporosis, osteopenia, osteoporosis